3Bemasconi A,Beghetei M. Inhaled nilic Oxide applications in paediatric practice[J]. Images Paediatr Cardiol, 2002,10 : 4-29. 被引量：1
4Hoffman TM, Wemovsky G Atz Am,et al. Prophylactic intrarenoususe of milrinone after cardiac operation in pediatrics(PRIMA CORP)study[J]. Am Heart J,2002,143(1) : 15-21. 被引量：1
2Galiè N,Hinderliter AL,Torbicki A,et al.Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension[J].J Am Coll Cardiol,2003,41:1380-1386. 被引量：1
3Barst RJ,Langleben D,Frost A,et al.Sitaxsentan,an ETA receptor antagonist,for the treatment of pulmonary arterial hypertension[J].Am J Respir Crit Care Med,2004,169:441-447. 被引量：1
4Rimensberger PC,Spahr-Schopfer I,Berner M,et al.Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease:vasodilator capacity and cellular mechanisms[J].Circulation,2001,103(4):544-548. 被引量：1
5Nagaya N,Uematsu M,Oya H,et al.Short-term oral administration of L-arginine improves hemodynamics and exercise capacity in patients with precapillary pulmonary hypertension[J].Am J Respir Crit Care Med,2001,163:887-891. 被引量：1
6Michelakis ED,Tymchak W,Noga M,et al.Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension[J].Circulation,2003,108:2066-2069. 被引量：1
7Petkov V,Mosgoeller W,Ziesche R,et al.Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension[J].J Clin Invest,2003,111:1339-1346. 被引量：1
8Marcos E,Adnot S,Pham MH,et al.Serotonin transporter inhibitors protect against hypoxic pulmonary hypertension[J].Am J Respir Crit Care Med,2003,168:487-493. 被引量：1
9Ad L,Birk E,Barak J,et al.A one-way valved atrial septal patch:a new surgical technique and its clinical application[J].J Thorac Cardiovasc Surg,1996,111(4):841-848. 被引量：1
10Franke U,Wiebe K,Harringer W,et al.Ten years experience with lung and heart-lung transplantation in primary and secondary pulmonary hypertension[J].Eur J Cardiothorac Surg,2000,18(4):447-452. 被引量：1
